Normal
9th -10th February 2023

5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference

San Diego, USA

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product & drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on microbiome vs probiotics and the link between them.

Connect with biotech, pharma, academicians and investors at 5th Annual Next Gen Microbiome and Probiotics Conference on 9-10 February 2023 in San Diego, USA, discussing the most ingenious research and technological advances. Key sessions on effective microbiome therapeutics in production, regulatory pathways, prebiotics probiotics and postbiotics along with discussion on effective translation from R&D to commercialization.

Co-Related Conferences
WHAT TO EXPECT

Key Highlights

  • Effective Microbiome Therapeutics in Production
  • Role of human skin microbiome in precision health
  • The increasing pro bacterial beauty industry
  • Business collaborations- Regulations and Investments
  • Microbiome as a science and its clinical applications- skin, gut & women’s health
  • Regulatory pathways
  • Prebiotics, Probiotics and Postbiotics
  • R&D to commercialization- effectively translating research into commercialization
  •  Rightly educating the consumer

Who Should Attend?

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

  • Microbiome discovery
  • Department of Biochemistry and Immunology
  • Microbiome science
  • Microbiology
  • Biological Science
  • Gut Biology
  • Human microbiome
  • Drug discovery
  • Therapeutics
  • Immunotherapy

Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of:

  • Microbiology
  • Microbiome therapeutics
  • Microbiome
  • Gastroenterology
  • Immunology
  • Bioinformatics
  • Obstetrics
  • Neonatology
  • Functional foods
  • Pediatrics
  • Nutritionists/dieticians
  • Gut inflammation
  • Mucosal immunity
  • Immunopharmacology Group
  • Gut disgiosis
  • Skin conditions
  • Baterria and excema gut and bacteria
  • Infant and gut
  • Pediatric and git
  • Gut brain axis

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
 Julius Goepp
Julius Goepp
Founder, CEO, Scaled Microbiomics
 Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer, Dakota Biotech
Peter Leighton
Peter Leighton
CEO, ProSperity Bioscience
Seth D. Crosby
Seth D. Crosby
Director, Research Collaborations, Washington University School of Medicine
Arun K. Bhunia
Arun K. Bhunia
Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease
Speakers
 Julius Goepp
Julius Goepp
Founder, CEO, Scaled Microbiomics
 Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer, Dakota Biotech
Peter Leighton
Peter Leighton
CEO, ProSperity Bioscience
Seth D. Crosby
Seth D. Crosby
Director, Research Collaborations, Washington University School of Medicine
Arun K. Bhunia
Arun K. Bhunia
Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease
 Emily Stein
Emily Stein
CEO, Primal Health Inc.
 Nicole M. Scott
Nicole M. Scott
CEO and Founder, Cybele Microbiome
Yug Varma
Yug Varma
CEO, Phi Therapeutics
LOCATION
San Diego, USA
About the Hotel

PAST EVENT GALLERY